Abramson Cancer Center multiple myeloma clinicians and researchers have led the way nationally for years in the diagnosis and treatment of multiple myeloma.
Today, there more hope than ever for those diagnosed with multiple myeloma. Our team has worked together for years. By putting our experience to work we offer the best possible treatment outcomes.
If diagnosed with Multiple Myeloma, it's important to have the best team of experts available.
At Penn's Multiple Myeloma Program there are individuals nationally recognized for their expertise. They can provide the information, care and support to help each step of the way.
Penn has one of the few Hematologic Malignancy (leukemia, lymphoma and myeloma) Research Programs in the country that is approved and funded by the National Cancer Institute.
The knowledge gained through our research allows us to better care for those with multiple myeloma.
To learn about what sets us apart, visit:
By the age of seven, Tanya Zekovitch already understood what it was like to be a cancer patient after being treated for Ewing's Sarcoma, a rare form of bone cancer. So when she was diagnosed with Acute Myeloid Leukemia in the summer of 2000, when she was still only in her early 20's, she felt lucky to find that Penn's Abramson Cancer Center offered patient support specialits and counselors to help patients cope with their diagnosis, not only to navigate the medical system, but also to address their emotional needs. Having benefited from counseling services when she was treated as a child, Tanya found Mindy Weismer, a Patient Service Coordinator, and they quickly developed a close relationship.
Focus On Blood Cancers and Bone Marrow Transplant Video
A patient education video with testimonies from our patients, doctors and researchers. Find out more about programs, treatment, research and care that is unique to the Abramson Cancer Center.